Humoral immune response to the hypervariable region of hepatitis C virus differs between genotypes 1b and 2a

Journal of Infectious Diseases

Volumn 175, Issue 3, 1997, Pages 505-510

  Yoshioka, Kentaro ^a   Aiyama, Toshiyuki ^b   Okumura, Akihiko ^b   Takayanagi, Masahiro ^b   Iwata, Kazuo ^b   Ishikawa, Tetsuya ^b   Nagai, Yoshiyuki ^b   Kakumu, Shinichi ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOGLOBULIN PRODUCTION; MALE; PRIORITY JOURNAL; VIRUS STRAIN;

EID: 0031024880     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.3.505     Document Type: Article

References (22)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
2. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
3. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12: 671-5.
4. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994;68:1494-500.
5. Farci P, Alter HJ, Wong DC, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 1994;91:7792-6.
6. Zibert A, Schreier E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 1995;208:653-61.
7. Kato N, Nakazawa T, Mizutani T, Shimotohno K. Susceptibility of human T-lymphotropic virus type 1 infected cell line MT-2 to hepatitis C virus infection. Biochem Biophys Res Commun 1995;206:863-9.
8. Weiner AJ, Geysen HM, Christopherson C, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992;89:3468-72.
9. Kato N, Sekiya H, Ootsuyama Y, et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993;67:3923-30.
10. Taniguchi S, Okamoto H, Sakamoto M, et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology 1993; 195:297-301.
11. Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991;88:3392-6.
12. Weiner AJ, Brauer MJ, Rosenblatt J, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS I proteins and the pestivirus envelope glycoproteins. Virology 1991;180:842-8.
13. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991;175:220-8.
14. Martell M, Esteban JI, Quer J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Gen Virol 1992;66:3225-9.
15. Higashi Y, Kakumu S, Yoshioka K, et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 1992;197:659-68.
16. Yoshioka K, Higashi Y, Tanaka K, et al. Deficiency of antibody response to hypervariable region of hepatitis C virus in patients with chronic hepatitis C. J Hepatol 1996;24:649-57.
17. Yoshioka K, Kakumu S, Wakita T, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992;16:293-9.
18. Silini E, Bono F, Cividini A, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 1995;21:285-90.
19. Feray C, Gigou M, Samuel D, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1088-96.
20. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical survey and tracing infectious sources. J Gen Virol 1992;73:673-9.
21. Simmonds P, McOmish F, Yap PL, et al. Sequence variability in the 5′ noncoding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993;74:661-8.
22. Laemmli A. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970;227:680-5.